Correlation Between Geron and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Geron and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Geron and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Geron and Candel Therapeutics, you can compare the effects of market volatilities on Geron and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Geron with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Geron and Candel Therapeutics.
Diversification Opportunities for Geron and Candel Therapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Geron and Candel is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Geron and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Geron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Geron are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Geron i.e., Geron and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Geron and Candel Therapeutics
Given the investment horizon of 90 days Geron is expected to generate 0.57 times more return on investment than Candel Therapeutics. However, Geron is 1.75 times less risky than Candel Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Candel Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 487.00 in Geron on September 12, 2024 and sell it today you would lose (88.00) from holding Geron or give up 18.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Geron vs. Candel Therapeutics
Performance |
| Timeline |
| Geron |
| Candel Therapeutics |
Geron and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Geron and Candel Therapeutics
The main advantage of trading using opposite Geron and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Geron position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Geron vs. Viking Therapeutics | Geron vs. TG Therapeutics | Geron vs. X4 Pharmaceuticals | Geron vs. PDS Biotechnology Corp |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |